🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-center, Phase II trial designed to estimate i...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2020-01-30
Trial ID
NCT04435977
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This is a dose-ranging study designed to investigate the efficacy and safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-12
Trial ID
NCT01490632
Treatments Being Tested
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The overall goal of this exploratory proof-of-concept study is to determine...
Status
Completed
Location
Task Applied Science and Stellenbosch University
Start Date
2017-08-23
Trial ID
NCT03174184
This is a single-center, prospective, single-arm, open-label phase II study...
Status
Completed
Location
Asan Medical Center
Start Date
2012-09
Trial ID
NCT01719549
Treatments Being Tested
Randomized, placebo-controlled trial with a 2x2 factorial design testing th...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2020-09-03
Trial ID
NCT04192136
Treatments Being Tested
Rationale Acute ischemic stroke due to atrial fibrillation (AF) carries a h...
Status
Completed
Location
Asan Medical Center
Start Date
2014-01
Trial ID
NCT02042534
Treatments Being Tested
The purpose of this study is to investigate the safety and pharmacokinetics...
Status
Completed
Location
Clinical Trials Center, Seoul National University Hospital
Start Date
2011-05
Trial ID
NCT01348516
Treatments Being Tested
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested